Nautilus Biotechnolgy's total assets for Q3 2024 were $259.70M, a decrease of -4.78% from the previous quarter. NAUT total liabilities were $36.27M for the fiscal quarter, a -3.20% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.